Skip to content
LexBuild

Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science; Notice of Meeting; Correction

---
identifier: "/us/fr/03-9384"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science; Notice of Meeting; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "03-9384"
section_name: "Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science; Notice of Meeting; Correction"
positive_law: false
currency: "2003-04-17"
last_updated: "2003-04-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-9384"
document_type: "notice"
publication_date: "2003-04-17"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "68 FR 18991"
fr_volume: 68
fr_action: "Notice; correction."
---

#  Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science; Notice of Meeting; Correction

**AGENCY:**

Food and Drug Adminstration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of April 3, 2003 (68 FR 16292). The notice announced a meeting of the Clinical Pharmacology Subcommittee of the Advisory Committee for Pharmaceutical Science, which was scheduled for April 22-23, 2003. The document was published with an error. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 03-8011, appearing on page 16292 in the *Federal Register* of Thursday, April 3, 2003, the following correction is made:

1. On page 16292, in the first column, in the “ *Location* ” section, “5600” is corrected to read “5630”.

Dated:  April 10, 2003.

Linda Arey Skladany,

Associate Commissioner for External Relations.